Comparative analysis of structurally defined heparin binding sequences reveals a distinct spatial distribution of basic residues.

[1]  M. Sobel,et al.  Design and synthesis of a helix heparin-binding peptide. , 1992, Biochemistry.

[2]  M. Sobel,et al.  Localization and characterization of a heparin binding domain peptide of human von Willebrand factor. , 1992, The Journal of biological chemistry.

[3]  A. Lellouch,et al.  A peptide model for the heparin binding site of antithrombin III. , 1992, Biochemistry.

[4]  G. M. Fox,et al.  Binding of heparin to basic fibroblast growth factor induces a conformational change. , 1992, Archives of biochemistry and biophysics.

[5]  K. Tryggvason,et al.  Human basement membrane heparan sulfate proteoglycan core protein: a 467-kD protein containing multiple domains resembling elements of the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor , 1992, The Journal of cell biology.

[6]  D. Rees,et al.  Three-dimensional structures of acidic and basic fibroblast growth factors. , 1993, Science.

[7]  J. Schwarzbauer,et al.  Localization of the major heparin-binding site in fibronectin. , 1991, The Journal of biological chemistry.

[8]  R L Jackson,et al.  Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes. , 1991, Physiological reviews.

[9]  Erkki Ruoslahti,et al.  Proteoglycans as modulators of growth factor activities , 1991, Cell.

[10]  Jeffrey D. Esko,et al.  Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor , 1991, Cell.

[11]  J. Hirsh.  Drug therapy : heparin , 1991 .

[12]  R. Jackson,et al.  Molecular design and modeling of protein-heparin interactions. , 1991, Methods in enzymology.

[13]  Z. Fuks,et al.  Extracellular sequestration and release of fibroblast growth factor: a regulatory mechanism? , 1991, Trends in biochemical sciences.

[14]  J. Smith,et al.  Heparin binding domain of antithrombin III: characterization using a synthetic peptide directed polyclonal antibody. , 1990, Biochemistry.

[15]  X. J. Sun,et al.  Evidence that arginine-129 and arginine-145 are located within the heparin binding site of human antithrombin III. , 1990, Biochemistry.

[16]  L. Furcht,et al.  Human keratinocytes adhere to a unique heparin-binding peptide sequence within the triple helical region of type IV collagen. , 1990, The Journal of investigative dermatology.

[17]  I. Kato,et al.  Primary structure of the heparin-binding site of type V collagen. , 1990, Biochimica et biophysica acta.

[18]  C. Romanin,et al.  Heparin binds with high affinity to voltage-dependent L-type Ca2+ channels. Evidence for an agonistic action. , 1990, The Journal of biological chemistry.

[19]  K. Mayo,et al.  Human Platelet Factor 4 and Its C-Terminal Peptides: Heparin Binding and Clearance from the Circulation , 1990, Thrombosis and Haemostasis.

[20]  M. Seno,et al.  Carboxyl-terminal structure of basic fibroblast growth factor significantly contributes to its affinity for heparin. , 1990, European journal of biochemistry.

[21]  R. St Charles,et al.  The three-dimensional structure of bovine platelet factor 4 at 3.0-A resolution. , 1989, The Journal of biological chemistry.

[22]  E. Tsilibary,et al.  Mapping of three major heparin-binding sites on laminin and identification of a novel heparin-binding site on the B1 chain. , 1989, The Journal of biological chemistry.

[23]  X. J. Sun,et al.  Heparin binding domain of human antithrombin III inferred from the sequential reduction of its three disulfide linkages. An efficient method for structural analysis of partially reduced proteins. , 1989, The Journal of biological chemistry.

[24]  B. Casu,et al.  Structure of Heparin and Heparin Fragments , 1989, Annals of the New York Academy of Sciences.

[25]  P. Andrews,et al.  Analysis of the biotin-binding site on acetyl-CoA carboxylase from rat. , 1989, European journal of biochemistry.

[26]  R. Eckel,et al.  Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases. , 1989, The New England journal of medicine.

[27]  E. Tsilibary,et al.  The binding of heparin to type IV collagen: domain specificity with identification of peptide sequences from the alpha 1(IV) and alpha 2(IV) which preferentially bind heparin. , 1989, The Journal of biological chemistry.

[28]  R. Akeson,et al.  Identification of a heparin binding domain of the neural cell adhesion molecule N-CAM using synthetic peptides , 1989, Neuron.

[29]  R Guillemin,et al.  Receptor- and heparin-binding domains of basic fibroblast growth factor. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. Esko,et al.  Adhesion of glycosaminoglycan-deficient chinese hamster ovary cell mutants to fibronectin substrata , 1988, The Journal of cell biology.

[31]  J. Chang,et al.  The heparin binding site of human antithrombin III. Selective chemical modification at Lys114, Lys125, and Lys287 impairs its heparin cofactor activity. , 1987, The Journal of biological chemistry.

[32]  S. O’Brien,et al.  Human endothelial cell growth factor: cloning, nucleotide sequence, and chromosome localization. , 1986, Science.

[33]  M. Karnovsky,et al.  Structural determinants of the capacity of heparin to inhibit the proliferation of vascular smooth muscle cells. II. Evidence for a pentasaccharide sequence that contains a 3-O-sulfate group , 1986, The Journal of cell biology.

[34]  R. Mahley,et al.  Human apolipoprotein E. Determination of the heparin binding sites of apolipoprotein E3. , 1986, The Journal of biological chemistry.

[35]  J. Sparrow,et al.  Binding of a high reactive heparin to human apolipoprotein E: identification of two heparin-binding domains. , 1986, Biochemical and biophysical research communications.

[36]  J. Loscalzo,et al.  The interaction of platelet factor four and glycosaminoglycans. , 1985, Archives of biochemistry and biophysics.

[37]  G. Torri,et al.  Total synthesis of a heparin pentasaccharide fragment having high affinity for antithrombin III , 1984 .

[38]  J. Marcum,et al.  Anticoagulantly active heparin-like molecules from vascular tissue. , 1984, Biochemistry.

[39]  R. Jackson,et al.  Visualization of heparin-binding proteins by ligand blotting with 125I-heparin. , 1984, Analytical biochemistry.

[40]  L. McCoy,et al.  Primary structure of human platelet factor 4. , 1977, Thrombosis research.

[41]  H. Cohen,et al.  Purification and binding properties of human platelet factor four. , 1976, The Journal of biological chemistry.